Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Yuichiro KaiVishwa Jeet AmatyaKei KushitaniTakahiro KambaraRui SuzukiYasuhiro TsutaniYoshihiro MiyataMorihito OkadaYukio TakeshimaPublished in: Histopathology (2019)
MUC21 could be used as an additional, novel, negative immunohistochemical marker to differentiate mesothelioma from lung adenocarcinoma.
Keyphrases